Stock Comparison
ABBV vs GILD
AbbVie Inc and Gilead Sciences Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$447.62B
$158.77B
P/E (TTM)
123.6
17.4
Forward P/E
17.8
15.2
Price/Sales
7.1
5.3
Price/Book
50.5
6.8
EV/EBITDA
30.2
12.0
Dividend Yield
2.77%
2.58%
Profitability
Net Margin
5.79%
31.00%
Operating Margin
32.20%
39.30%
Return on Equity
62.30%
43.40%
Return on Assets
10.00%
13.30%
Growth (YoY)
Revenue Growth
12.40%
4.40%
Earnings Growth
-46.20%
54.80%
Price & Risk
Beta
0.3
0.3
52-Week High
$253.35
$155.38
52-Week Low
$176.02
$105.01
Analyst Target
$254.38
$157.57
Compare ABBV and GILD your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.